Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33252616.
- Also identified by DOI 10.1001/jamainternmed.2020.5017 and PMC identifier 7851728.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines national Medicaid and Medicare drug-spending data to examine colchicine prices over the period from 2008 to 2017.
Medical subject headings
- Cardiovascular Agents
- Colchicine